Halo-substituted piperidines as orexin receptor modulators
US11434236B2 · kind B2 · utility
1Cited by
5References
32Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 9, 2020 |
| Grant date | Sep 6, 2022 |
| Priority date | — |
| Expiry date | Dec 9, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application relates to certain halo-substituted piperidine compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating substance addiction, panic disorder, anxiety, post-traumatic stress disorder, pain, depression, seasonal affective disorder, an eating disorder, or hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.